In experimental studies, inhibition of HIF1α/VEGF-A signaling impairs angiogenesis during chronic pressure overload, leading to heart failure [20, 49], while VEGF-A treatment improves angiogenesis [12]. This evidence concerns the gene VEGFA and heart failure.